Vimarsana
Biggest News Aggregation in the World

Page 32 - Barry Bloom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Barry Bloom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Barry Bloom Today - Breaking & Trending Today

A Single Vaccine Dose Appears To Protect Against COVID-19. So Why Are We Giving Two? - Vimarsana News

A Single Vaccine Dose Appears To Protect Against COVID-19. So Why Are We Giving Two?

Tucked inside the Food and Drug Administration’s analyses of Moderna and Pfizer's vaccines was a pleasant discovery: A single injection of either of the two-dose vaccines appears to provide strong protection against the coronavirus. With supplies of the vaccines limited — and hundreds of millions of people waiting for inoculation — this leaves epidemiologists grappling with a complicated question. Should the nation vaccinate fewer people with the best protection possible, or provide twice the number of people with a single shot, covering more of the population but with slightly we...

Source: wbur.org
FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting - Vimarsana News

FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting

FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting Karen Weintraub, USA TODAY Replay Video UP NEXT This time, the committee is reviewing a vaccine made by Cambridge, Massachusetts, biotech Moderna, with similar technology and results as the one it supported last week by Pfizer and its German collaborator, BioNTech.  A clinical trial in 30,000 volunteers showed that the Moderna vaccine is more than 94% effective in preventing COVID-19, including serious disease. The vaccine causes frequent side effects like sore arms, fat...

Source: msn.com
As The FDA Reviews Moderna's Vaccine, Scientists Are Already Celebrating - Vimarsana News

As The FDA Reviews Moderna's Vaccine, Scientists Are Already Celebrating

In this July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. (Hans Pennink/AP) For the second time in two weeks, the FDA is on the cusp of authorizing a coronavirus vaccine. This one is from Cambridge-based Moderna. After reviewing a Food and Drug Administration evaluation of data from clinical trials released on Tuesday, health experts expect a repeat of the Pfizer vaccine’s prompt emergency authorization last week. “If people read the 53 pages of th...

Source: wbur.org
[WEBCAST] COVID-19 Vaccines: What to Expect in 2021 - Vimarsana News

[WEBCAST] COVID-19 Vaccines: What to Expect in 2021

Since the first COVID-19 case was reported, millions of individuals have been infected worldwide, with over a million deaths attributed to the virus. The pandemic has also severely impacted economies worldwide, and countries have long awaited the development of a vaccine to combat the disease. Following several rounds of lockdowns in the U.S. and other countries, multiple vaccine candidates have finally been approved and are being distributed in the U.S. and across the world. As vaccines become more widely available, new questions arise for scientists, public health officials, and governm...

How Massachusetts will roll out COVID-19 vaccines - Vimarsana News

How Massachusetts will roll out COVID-19 vaccines

How Massachusetts will roll out COVID-19 vaccines Frontline health care workers, residents of nursing homes and long-term-care facilities, emergency workers, and staff and residents of prisons and homeless shelters will be among the first to receive COVID-19vaccinations in Massachusetts. At a December 9, 2020, press conference, Gov. Charlie Baker said the state plans to distribute more than 2 million doses by the end of March 2021, and that the vaccine will be free to everyone. He said that the timing of the rollout would depend on federal authorizations for the vaccines. The Baker administra...